Antienite
- Level
- Commodity
- Parent
- 51101600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51101634This classification denotes an antihelminthic agent with the molecular formula C9H8N2S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 50Z1JVP72H, chemically known as imidazo(2,1-b)thiazole, 5,6-dihydro-6-(2-thienyl)-, ( -)- but generally known as antienite, which bears US NIH Compound Identifier 170351. European Medicines Agency schedules Antienite in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05529MIG. The term ANTIENITE is an International Non-Proprietary Name. ANTIENITE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule antienite under HS 29349990 and SITC 51579. As of Q4 2014, ANTIENITE remains the US FDA Preferred Term for this commodity. Antienite bears US NLM identifiers UMLS ID C2346831 and NCI Concept Code C74151. SMILES: S1C2=NC(CN2CC1)C1SCCC1.
Same parent
Under 51101600 · 77Activities that produce or sell this
KBLI · 8Inherited from family 51100000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.